The process combines a membrane bioreactor (MBR) and nanofiltrati

The process combines a membrane bioreactor (MBR) and nanofiltration (NF) technology to treat

the leachate. The results indicate that the NF system, including the hollow-fiber NF membrane, is an appropriate advanced treatment alternative for landfill leachates. This system provided good removal of chemical oxygen demand and color. The membrane flux renewal reached over 96% after washing with 0.01 mol/L HCl. As a result, the effluent water quality met effluent discharge standards (GB16889-2008). (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 116: 2343-2347, 2010″
“Objective-To evaluate the incidence of sterile hemorrhagic cystitis (SHC) and other adverse effects in dogs following oral administration of the single-day,

maximum-tolerated dose (MTD) of cyclophosphamide divided over 3 days as part of a multiagent chemotherapy protocol for treatment of learn more lymphoma without concurrent administration of furosemide.

Design-Retrospective case series.

Animals-57 dogs.

Procedures-Medical records were reviewed to identify dogs with see more lymphoma that underwent the described cyclophosphamide treatment. Information was obtained regarding signalment, lymphoma stage, concurrent diseases, cyclophosphamide doses administered, adverse effects (including SHC), remission rates, and outcomes. The incidence of SHC was compared with that of literature-derived historical control groups that received the MTD of cyclophosphamide as a single, 1-day dose with or without furosemide treatment.

Results-None of the 57 dogs developed SHC during the study period. Forty-seven of 57 (82%) dogs had complete remission of lymphoma. Other adverse effects were uncommon and self-limiting; no dogs had myelosuppression, and only 5 had mild gastrointestinal effects. Incidence of SHC was significantly lower than that reported for historical control dogs that received cyclophosphamide as a single dose without furosemide (24/219) and was not significantly different from that for historical control dogs that received cyclophosphamide

as a single dose with furosemide check details (2/139).

Conclusions and Clinical Relevance-No dogs in this study had SHC following oral administration of the single-day MTD of cyclophosphamide divided over a 3-day period without furosemide administration. Further research is needed to confirm whether this method of cyclophosphamide administration is equivalent or superior to the current single-dose administration method.”
“Fe65Co35 /underlayer bilayer films were successfully prepared on different underlayer materials (Co93Fe7, Ni80Fe20, Cu, and Fe). The soft magnetic properties of Fe65Co35 films were improved when the texture changed from (110) to (200), which can be controlled by different underlayers. The conversion electron Mossbauer spectroscopy revealed that the angle between the effective magnetization and the normal direction of films with (110) texture is smaller than that with (200) texture.

Comments are closed.